|
|
|
|
|
|
||
|
|
||||
|
|
||||
|
||||
Retrospective Clinical Study |
Departments of Neurosurgery (R.J.J., D.A.-S., F.F.L, Z.L.G., W.M.S., D.M.W., R.S.) and Pathology (G.N.F.), The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030
3 Address correspondence and reprint requests to Raymond Sawaya, Department of Neurosurgery, Box 442, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030.
Abstract
Stereotactic biopsy is often performed for diagnostic purposes before treating patients whose imaging studies highly suggest glioma. Indications cited for biopsy include diagnosis and/or the "inoperability" of the tumor. This study questions the routine use of stereotactic biopsy in the initial management of gliomas. At The University of Texas M. D. Anderson Cancer Center, we retrospectively reviewed a consecutive series of 81 patients whose imaging studies suggested glioma and who underwent stereotactic biopsy followed by craniotomy/resection (within 60 days) between 1993 and 1998. All relevant clinical and imaging information was reviewed, including computerized volumetric analysis of the tumors based on pre- and postoperative MRI. Stereotactic biopsy was performed at institutions other than M. D. Anderson in 78 (96%) of 81 patients. The majority of tumors were located either in eloquent brain (36 of 81 = 44%) or near-eloquent brain (41 of 81 = 51%), and this frequently was the rationale cited for performing stereotactic biopsy. Gross total resection (>95%) was achieved in 46 (57%) of 81 patients, with a median extent of resection of 96% for this series. Diagnoses based on biopsy or resection in the same patient differed in 40 (49%) of 82 cases. This discrepancy was reduced to 30 (38%) of 80 cases when the biopsy slides were reviewed preoperatively by each of three neuropathologists at M. D. Anderson. Major neurologic complications occurred in 10 (12.3%) of 81 surgical patients and 3 (3.7%) of 81 patients undergoing biopsy. Surgical morbidity was probably higher in our series than it would be for glioma patients in general because our patients represent a highly selected subset of glioma patients whose tumors present a technical challenge to remove. Stereotactic biopsy is frequently inaccurate in providing a correct diagnosis and is associated with additional risk and cost. If stereotactic biopsy is performed, expert neuropathology consultation should be sought.
References
Abi-Said, D., Lacroix, M., Shi, W., Gokaslan, Z.L., Hess, K., DeMonte, F., Lang, F.F., McCutcheon, I.E., Hassenbusch, S.J., Michael, C., Miller, D., and Sawaya, R. (1999) Imaging-based necrosis and the survival of patients with glioblastoma multiforme. Neuro-Oncology [serial online], Doc. N1, September 29, 1999. URL http://neuro-oncology.mc.duke.edu. Neuro-Oncol. 1,294 . (Abstract)
Apuzzo, M.L., Chandrasoma, P.T., Cohen, D., Zee, C.S., and Zelman, V. (1987) Computed imaging stereotaxy: Experience and perspective related to 500 procedures applied to brain masses. Neurosurgery 20,930 -937.[Web of Science][Medline]
Bernstein, M., and Parrent, A.G. (1994) Complications of CT-guided stereotactic biopsy of intra-axial brain lesions. J. Neurosurg. 81,165 -168.[Web of Science][Medline]
Broggi, G., Franzini, A., Giorgi, C., and Allegranza, A. (1984) Diagnostic accuracy and multimodal approach in stereotactic biopsies of deep brain tumors. Acta Neurochir. Suppl. 33,211 -212.
Bruner, J.M., Inouye, L., Fuller, G.N., and Langford, L.A. (1997) Diagnostic discrepancies and their clinical impact in a neuropathology referral practice. Cancer 79,796 -803.[CrossRef][Web of Science][Medline]
Chandrasoma, P.T., Smith, M.M., and Apuzzo, M.L. (1989) Stereotactic biopsy in the diagnosis of brain masses: Comparison of results of biopsy and resected surgical specimen. Neurosurgery 24,160 -165.[Web of Science][Medline]
Coffey, R.J., and Lunsford, L.D. (1985) Stereotactic surgery for mass lesions of the midbrain and pons. Neurosurgery 17,12 -18.[Web of Science][Medline]
Danks, R.A., Chopra, G., Gonzales, M.F., Orian, J.M., and Kaye, A.H. (1995) Aberrant p53 expression does not correlate with the prognosis in anaplastic astrocytoma. Neurosurgery 37,246 -254.[Web of Science][Medline]
Devaux, B.C., O'Fallon, J.R., and Kelly, P.J. (1993) Resection, biopsy, and survival in malignant glial neoplasms: A retrospective study of clinical parameters, therapy, and outcome. J. Neurosurg. 78,767 -775.[Web of Science][Medline]
Fadul, C., Wood, J., Thaler, H., Galicich, J., Patterson, R.H.,
Jr., and Posner, J.B. (1988) Morbidity and mortality of
craniotomy for excision of supratentorial gliomas.
Neurology 38,1374
-1379.
Feiden, W., Steude, U., Bise, K., and Gundisch, O. (1991) Accuracy of stereotactic brain tumor biopsy: Comparison of the histologic findings in biopsy cylinders and resected tumor tissue. Neurosurg. Rev. 14,51 -56.[Web of Science][Medline]
Fuller, G.N. (1996) Central nervous system tumors. In: Parham, D.M. (Ed.), Pediatric Neoplasia: Morphology and Biology. Philadelphia, Pa.: Lippincott-Raven. pp.153 -204.
Fulling, K.H., and Nelson, J.S. (1984) Cerebral astrocytic neoplasms in the adult: Contribution of histologic examination to the assessment of prognosis. Semin. Diagn. Pathol. 1, 152-163.[Medline]
Gaudin, P.B., Sherman, M.E., Brat, D.J., Zahurak, M., and Erozan, Y.S. (1997) Accuracy of grading gliomas on CT-guided stereotactic biopsies: A survival analysis. Diagn. Cytopathol. 17,461 -466.[CrossRef][Web of Science][Medline]
Glantz, M.J., Burger, P.C., Herndon, J.E., II, Friedman, A.H.,
Cairncross, J.G., Vick, N.A., and Schold, S.C., Jr. (1991)
Influence of the type of surgery on the histologic diagnosis in patients with
anaplastic gliomas. Neurology
41,1741
-1744.
Hall, W.A. (1998) The safety and efficacy of stereotactic biopsy for intracranial lesions. Cancer 82,1749 -1755.[CrossRef][Web of Science][Medline]
Iacoangeli, M., Roselli, R., Prezioso, A., Scerrati, M., and Rossi, G.F. (1993) Staging of supratentorial hemispheric glioma using tumour extension, histopathological grade and extent of surgical resection. Br. J. Surg. 80,1130 -1133.[Web of Science][Medline]
Janny, P., Cure, H., Mohr, M., Heldt, N., Kwiatkowski, F., Lemaire, J.J., Plagne, R., and Rozan, R. (1994) Low grade supratentorial astrocytomas: Management and prognostic factors. Cancer 73,1937 -1945.[CrossRef][Web of Science][Medline]
Kepes, J.J. (1994) Pitfalls and problems in the histopathologic evaluation of stereotactic needle biopsy specimens. Neurosurg. Clin. N. Am. 5, 19-33.[Medline]
Kim, J.-H., and Gildenberg, P.L. (1998) Stereotactic biopsy. In: Gildenberg, P.L., and Tasker, R.R. (Eds.), Textbook of Stereotactic and Functional Neurosurgery. New York: McGraw-Hill. pp. 387-396.
Kleihues, P., Volk, B., Anagnostopoulos, J., and Kiessling, M. (1984) Morphologic evaluation of stereotactic brain tumour biopsies. Acta Neurochir. Suppl. (Wien) 33,171 -181.[Medline]
Kreth, F.W., Warnke, P.C., Scheremet, R., and Ostertag, C.B. (1993) Surgical resection and radiation therapy versus biopsy and radiation therapy in the treatment of glioblastoma multiforme. J. Neurosurg. 78,762 -766.[Web of Science][Medline]
Levin, V.A., Prados, M.R., Wara, W.M., Davis, R.L., Gutin, P.H., Phillips, T.L., Lamborn, K., and Wilson, C.B. (1995) Radiation therapy and bromodeoxyuridine chemotherapy followed by procarbazine, lomustine, and vincristine for the treatment of anaplastic gliomas. Int. J. Radiat. Oncol. Biol. Phys. 32, 75-83.[CrossRef][Web of Science][Medline]
Lunsford, L.D., Somaza, S., Kondziolka, D., and Flickinger, J.C. (1995) Survival after stereotactic biopsy and irradiation of cerebral nonanaplastic, nonpilocytic astrocytoma. J. Neurosurg. 82,523 -529.[Web of Science][Medline]
Mittler, M.A., Walters, B.C., and Stopa, E.G. (1996) Observer reliability in histological grading of astrocytoma stereotactic biopsies. J. Neurosurg. 85,1091 -1094.[Web of Science][Medline]
Mundinger, F. (1985) CT stereotactic biopsy for optimizing the therapy of intracranial processes. Acta Neurochir. Suppl. (Wien) 35,70 -74.[Medline]
Nitta, T., and Sato, K. (1995) Prognostic implications of the extent of surgical resection in patients with intracranial malignant gliomas. Cancer 75,2727 -2731.[CrossRef][Web of Science][Medline]
Ostertag, C.B., Mennel, H.D., and Kiessling, M. (1980) Stereotactic biopsy of brain tumors. Surg. Neurol. 14,275 -283.[Web of Science][Medline]
Piepmeier, J., Christopher, S., Spencer, D., Byrne, T., Kim, J., Knisel, J.P., Lacy, J., Tsukerman, L., and Makuch, R. (1996) Variations in the natural history and survival of patients with supratentorial low-grade astrocytomas. Neurosurgery 38,872 -879.[CrossRef][Web of Science][Medline]
Pollack, I.F., Claassen, D., al-Shboul, Q., Janosky, J.E., and Deutsch, M. (1995) Low-grade gliomas of the cerebral hemispheres in children: An analysis of 71 cases. J. Neurosurg. 82,536 -547.[Web of Science][Medline]
Revesz, T., Scaravilli, F., Coutinho, L., Cockburn, H., Sacares,
P., and Thomas, D.G. (1993) Reliability of histological diagnosis
including grading in gliomas biopsied by image-guided stereotactic technique.
Brain 116,781
-793.
Rostomily, R.C., Spence, A.M., Duong, D., McCormick, K., Bland, M., and Berger, M.S. (1994) Multimodality management of recurrent adult malignant gliomas: Results of a phase II multiagent chemotherapy study and analysis of cytoreductive surgery. Neurosurgery 35,378 -388.[Web of Science][Medline]
Sawaya, R., Hammoud, M., Schoppa, D., Hess, K.R., Wu, S.Z., Shi, W.M., and Wildrick, D.M. (1998) Neurosurgical outcomes in a modern series of 400 craniotomies for treatment of parenchymal tumors. Neurosurgery 42,1044 -1056.[CrossRef][Web of Science][Medline]
Sawin, P.D., Hitchon, P.W., Follett, K.A., and Torner, J.C. (1998) Computed imaging-assisted stereotactic brain biopsy: A risk analysis of 225 consecutive cases. Surg. Neurol. 49,640 -649.[CrossRef][Web of Science][Medline]
Scerrati, M., and Rossi, G.F. (1984) The reliability of stereotactic biopsy. Acta Neurochir. Suppl. 33,201 -205.
Sedan, R., Peragut, J.C., Farnarier, P.H., Hassoun, J., and Sethian, M. (1984) Intra-encephalic stereotactic biopsies (309 patients/318 biopsies). Acta Neurochir. Suppl. 33,207 -210.
Shi, W.-M., Wildrick, D.M., and Sawaya, R. (1998) Volumetric measurement of brain tumors from MR imaging. J. Neurooncol. 37,87 -93.[CrossRef][Medline]
Smith, M.T., Ludwig, C.L., Godfrey, A.D., and Armbrustmacher, V.W. (1983) Grading of oligodendrogliomas. Cancer 52,2107 -2114.[CrossRef][Web of Science][Medline]
Vecht, C.J., Avezaat, C.J., van Putten, W.L., Eijkenboom, W.M., and
Stefanko, S.Z. (1990) The influence of the extent of surgery on
the neurological function and survival in malignant glioma: A retrospective
analysis in 243 patients. J. Neurol. Neurosurg.
Psychiatry 53,466
-471.
Whiting, D.M., Barnett, G.H., Estes, M.L., Sila, C.A., Rudick, R.A., Hassenbusch, S.J., and Lanzieri, C.F. (1992) Stereotactic biopsy of non-neoplastic lesions in adults. Cleve. Clin. J. Med. 59,48 -55.[Web of Science][Medline]
Willems, J.G., and Alva-Willems, J.M. (1984) Accuracy of cytologic diagnosis of central nervous system neoplasms in stereotactic biopsies. Acta Cytol. 28,243 -249.[Web of Science][Medline]
Winger, M.J., Macdonald, D.R., and Cairncross, J.G. (1989) Supratentorial anaplastic gliomas in adults: The prognostic importance of extent of resection and prior low-grade glioma. J. Neurosurg. 71,487 -493.[Web of Science][Medline]
CiteULike 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Bisdas, M. Kirkpatrick, P. Giglio, C. Welsh, M.V. Spampinato, and Z. Rumboldt Cerebral Blood Volume Measurements by Perfusion-Weighted MR Imaging in Gliomas: Ready for Prime Time in Predicting Short-Term Outcome and Recurrent Disease? AJNR Am. J. Neuroradiol., April 1, 2009; 30(4): 681 - 688. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Hirai, R. Murakami, H. Nakamura, M. Kitajima, H. Fukuoka, A. Sasao, M. Akter, Y. Hayashida, R. Toya, N. Oya, et al. Prognostic Value of Perfusion MR Imaging of High-Grade Astrocytomas: Long-Term Follow-Up Study AJNR Am. J. Neuroradiol., September 1, 2008; 29(8): 1505 - 1510. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Law, R. J. Young, J. S. Babb, N. Peccerelli, S. Chheang, M. L. Gruber, D. C. Miller, J. G. Golfinos, D. Zagzag, and G. Johnson Gliomas: Predicting Time to Progression or Survival with Cerebral Blood Volume Measurements at Dynamic Susceptibility-weighted Contrast-enhanced Perfusion MR Imaging Radiology, May 1, 2008; 247(2): 490 - 498. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Lu, E. Pollack, R. Young, J.S. Babb, G. Johnson, D. Zagzag, R. Carson, J.H. Jensen, J.A. Helpern, and M. Law Predicting Grade of Cerebral Glioma Using Vascular-Space Occupancy MR Imaging AJNR Am. J. Neuroradiol., February 1, 2008; 29(2): 373 - 378. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.K. Ellika, R. Jain, S.C. Patel, L. Scarpace, L.R. Schultz, J.P. Rock, and T. Mikkelsen Role of Perfusion CT in Glioma Grading and Comparison with Conventional MR Imaging Features AJNR Am. J. Neuroradiol., November 1, 2007; 28(10): 1981 - 1987. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Chen Clinical Applications of PET in Brain Tumors J. Nucl. Med., September 1, 2007; 48(9): 1468 - 1481. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Law, R. Young, J. Babb, M. Rad, T. Sasaki, D. Zagzag, and G. Johnson Comparing Perfusion Metrics Obtained from a Single Compartment Versus Pharmacokinetic Modeling Methods Using Dynamic Susceptibility Contrast-Enhanced Perfusion MR Imaging with Glioma Grade. AJNR Am. J. Neuroradiol., October 1, 2006; 27(9): 1975 - 1982. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. F. Lang and M. R. Gilbert Diffusely Infiltrative Low-Grade Gliomas in Adults J. Clin. Oncol., March 10, 2006; 24(8): 1236 - 1245. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Law, S. Oh, J. S. Babb, E. Wang, M. Inglese, D. Zagzag, E. A. Knopp, and G. Johnson Low-Grade Gliomas: Dynamic Susceptibility-weighted Contrast-enhanced Perfusion MR Imaging--Prediction of Patient Clinical Response Radiology, February 1, 2006; 238(2): 658 - 667. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. B. Pope, J. Sayre, A. Perlina, J. P. Villablanca, P. S. Mischel, and T. F. Cloughesy MR Imaging Correlates of Survival in Patients with High-Grade Gliomas AJNR Am. J. Neuroradiol., November 1, 2005; 26(10): 2466 - 2474. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C. M. Maia Jr, S. M. F. Malheiros, A. J. da Rocha, C. J. da Silva, A. A. Gabbai, F. A. P. Ferraz, and J. N. Stavale MR Cerebral Blood Volume Maps Correlated with Vascular Endothelial Growth Factor Expression and Tumor Grade in Nonenhancing Gliomas AJNR Am. J. Neuroradiol., April 1, 2005; 26(4): 777 - 783. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Evans, K. D. Judy, I. Dunphy, W. T. Jenkins, W.-T. Hwang, P. T. Nelson, R. A. Lustig, K. Jenkins, D. P. Magarelli, S. M. Hahn, et al. Hypoxia Is Important in the Biology and Aggression of Human Glial Brain Tumors Clin. Cancer Res., December 15, 2004; 10(24): 8177 - 8184. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
